Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-09-006255

Options or other derivatives

  • Chief Financial Officer acquired 400,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Lamadrid David Chief Financial Officer 2009-01-28 Grant or award · Stock Option +400,000 4,700,000 D
Loading xslF345X03/v139321_ex.xml…